Khalife Wissam I, Mahmoud Fade, Larson Eric, Hardie Richard
USD School of Medicine, IM Residency Program, Sioux Falls, SD, USA.
S D J Med. 2005 Apr;58(4):139-43.
Lymphangioleiomyomatosis (LAM) is a rare disorder that occurs almost exclusively in young females and characterized by peribronchial, perivascular, and perilymphatic non-neoplastic proliferation of smooth-muscle cells. These changes may precipitate chylous effusions, pulmonary hemorrhage, bronchial cyst formation, progressive loss of lung function, and ultimately death. Most patients die within eight to ten years of the time of diagnosis. We report a rare case ofpost-menopausal onset pulmonary lymphangioleiomyomatosis in a 62-year old Caucasian female that was diagnosed at age 53 and responded well to intramuscular injections of Depo-Provera and bilateral oophorectomy. No symptom progression or pulmonary function test deterioration was noted over an eight year period of clinical follow-up. Our case is unique because of the postmenopausal onset and the unusual clinical course of the disease.
淋巴管平滑肌瘤病(LAM)是一种罕见疾病,几乎仅发生于年轻女性,其特征为支气管周围、血管周围和淋巴管周围平滑肌细胞的非肿瘤性增殖。这些改变可能导致乳糜性胸腔积液、肺出血、支气管囊肿形成、肺功能进行性丧失,最终导致死亡。大多数患者在诊断后八至十年内死亡。我们报告一例罕见的绝经后发病的肺淋巴管平滑肌瘤病,患者为一名62岁的白种女性,53岁时确诊,对肌肉注射醋酸甲羟孕酮和双侧卵巢切除术反应良好。在八年的临床随访期间,未观察到症状进展或肺功能测试恶化。我们的病例很独特,因为其绝经后发病以及疾病不寻常的临床病程。